Go to Top

Institut Mutualiste Montsouris

Institut Mutualiste Montsouris

75014 Paris, France   |   Accreditation: none listed 

 42 Boulevard Jourdan

75014 Paris

contact:

Manager International Patients

mdc@imm-international.org

+336 98721589

 

Features:

Institut Mutualiste Montsouris (IMM) is one of the leading French Hopsitals. IMM, with its 1,500 health professionals, is known for providing the highest quality patient care that modern medicine has to offer. IMM Medical teams dedication to excellence, compassion and innovation is testifying by the 2010 Le Point ranking, the annual French independent ranking inquiry about the French Health system. IMM ranked also in 2010 among the first ten hospitals in France in general and among the top in 5 categories.

IMM in figures:
– 456 beds, including 85% in individual bedrooms
– 337 beds of traditional hospitalization
– 35 beds of intensive care
– 44 beds of day Ward of surgery and medicine
– 30 beds of day Ward of psychiatry
– 10 dialysis units
– 17 operating rooms
– 8 medical imagery rooms

The homepage for the Institut Mutualiste Montsouris : www.imm.fr

For International Patients:

Institut Mutualiste Montsouris welcomes International Patients through www.imm-international.org This site is dedicated to non-French citizens or non-French residents. If you are an international patient, you can use the IMM International platform to share information about your medical situation in your native language and book your consultation or your surgery in IMM.

The website was designed to respond to international patients needs: 5 languages are available (Arabic, Japanese, English, Portugese, Italian).

All the personal and medical information is translated in English by professionals. We insure the completion and translation of all the medical files.

Specialties:

The specialities are:
– Cardiac Pathologies
– Digestive Pathologies
= Gynaecological Surgery
– Orthopaedics
– Thoracic
– Urology
The urological team is specialized in the treatment of prostate, kidney, bladder and testis cancers in collaboration with Institut Gustave Roussy and Institut Curie